Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis
Authors:
- 21 December 2006
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 25 (5) , 617-628
Abstract
Summary: Aim To assess the relationship between the percentage of time intragastric pH >4.0 and healing of erosive oesophagitis.Methods In this proof‐of‐concept study, adults with endoscopically verified Los Angeles grade C or grade D erosive oesophagitis were randomly assigned to oral esomeprazole 10 or 40 mg once daily for 4 weeks. On day 5, patients underwent 24‐h pH monitoring. At 4 weeks, erosive oesophagitis healing status was endoscopically assessed. Investigators scored gastro‐oesophageal reflux disease symptoms on a 4‐point scale [none to severe (0–3)] before and 4 weeks after treatment. The percentage of time intragastric pH was >4.0 and healing status were correlated and tested for significance using a Spearman rank correlation (r).Results 103 patients had evaluable data (mean age, 48.7 years; 65% men). Mean percentages of time with intragastric pH >4.0 on day 5 in patients with healed and unhealed erosive oesophagitis were 61% and 42%, respectively (P = 0.0002), indicating that erosive oesophagitis healing rates were positively related to the percentage of time intragastric pH was >4.0. Greater intragastric acid control correlated with lower final daytime and night‐time heartburn and acid regurgitation symptom scores (r = −0.029, −0.029 and −0.021; P = 0.003, 0.003 and 0.032, respectively).Conclusion A positive relationship between intragastric acid control and erosive oesophagitis healing was demonstrated.Keywords
This publication has 27 references indexed in Scilit:
- A Multicenter, Randomized, Double-Blind, 8-Week Comparative Trial of Standard Doses of Esomeprazole (40 mg) and Omeprazole (20 mg) for the Treatment of Erosive EsophagitisDigestive Diseases and Sciences, 2006
- Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2006
- Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitisAlimentary Pharmacology & Therapeutics, 2005
- Intragastric acid suppression and pharmacokinetics of twice‐daily esomeprazole: a randomized, three‐way crossover studyAlimentary Pharmacology & Therapeutics, 2004
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut, 1999
- Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.Gut, 1996
- Gastro-Oesophageal Reflux during 3 Months of Therapy with Ranitidine in Reflux OesophagitisScandinavian Journal of Gastroenterology, 1996
- Twenty‐four‐hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placeboAlimentary Pharmacology & Therapeutics, 1995
- Roles of Gastric Acid and pH in the Pathogenesis of Gastro-Oesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1994
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux DiseaseDigestion, 1992